| 期刊論文| 1. | Butler, JM.、Case, LD.、Atkins, J.(2007)。A PhaseIll, Double-Blind, Placebo- Controlled Prospective Randomized Clinical Trial of d-Threo-Methylphenidate HC1 in Brain Tumor Patients Receiving Radiation Therapy。Int J Radiat Oncol Biol Phys，69(5)，1496-1501。   | | 2. | Ross, SD.、Allen, IE.、Henry, DH.、Seaman, C.、Sercus, B.、Goodnough, LT.(200606)。Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature。Clin Ther，28(6)，801-831。 | | 3. | Flechtne, Hr.、Bottomley, A.(2003)。Fatigue and Quality of Life: Lessons from the Real World。The Oncologist，8(suppl 1)，5-9。 | | 4. | Gupta, D.、Lis, C. G.、Grutsch, J. F.(2007)。The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life In Cancer。J Pain Symptom Manage，34(1)，40-47。 | | 5. | Yeh, ET.、Lau, SC.、Su, WJ.、Tsai, DJ.、Tu, YY.、Lai, YL.(2011)。An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan。BMC，11，387。 | | 6. | Mustian, KM.、Morrow, GR.、Carroll, JK.、Figueroa-Moseley, CD.、Jean-Pierre, P.、Williams, GC.(2007)。Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue。The Oncologist，12(suppl 1)，52-67。 | | 7. | Horneber, M.、Fischer, I.、Dimeo, F.、Rüffer, J. U.、Weis, J.(2012)。Cancer-related fatigue: epidemiology, pathogenesis, Diagnosis, and treatment。Deutsches Ärzteblatt International，109(9)，161-172。 | | 8. | Sarhill, N.、Walsh, D.、Nelson, KA.、Homsi, J.、LeGrand, S.、Davis, MP.(2001)。Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study。AM J HOSP PALLIAT CARE，18(3)，187-192。 | | 9. | Schwartz, AL.、Thompson, JA.、Masood, N.(2002)。Interferon-induced fatigue in advanced cancer: a prospective open-label pilot study。Oncol Nus Forum，29(7)，E85-E90。 | | 10. | Sugawara, Y.、Akechi, T.、Shima, Y.(2002)。Efficacy of methylphenidate foe fatigue in advanced cancer patients: a preliminary study。Palliat Med，16，261-263。 | | 11. | Hanna, A.、Sledge, G.、Mayer, ML.、Hanna, N.(2006)。A phase II study of methylphenidate for the treatment of fatigue。Supportive Care in Cancer，14(3)，210-215。 | | 12. | Breitbart, H.、Alici, Y.(200810)。Pharmacologic treatment options for cancer-related fatigue: current state of clinical research。Clinical Journal of Oncology Nursing，12(suppl)，27-36。 | | 13. | Bmera, E.、Valero, V.、Driver, L.(2006)。Patient-Controlled Methylphenidate for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial。Journal of Clinical Oncology，24(13)，2073-2078。 | | 14. | Moraska, AR.、Sood, A.、Dakhil, SR.(20100810)。Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial。J Clin Oncol，28(23)，3673-3679。 | | 15. | Lower, E.、Fleishman, S.、Cooper, A.、Zeldis, J.、Faleck, H.、Manning, D.(2005)。A phaseIll randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and “ chemobrain” in adult cancer patients。J Clin Oncol，23(suppl 16)，8000。 | | 16. | Lower, EE.、Fleishman, S.、Cooper, A.(2009)。Efficacy of dexmethylphenidate for the treatment of fatigue After Cancer Chemotherapy: A Randomized Clinical Trial。J Pain Symptom Manage，38(5)，650-662。 | | 17. | Rammohan, KW.、Rosenberg, JH.、Lynn, DJ.、Blumenfeld, AM.、Poliak, CP.、Nagaraja, HN.(2002)。Efficacy and safety of modafinil (Provigil ®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study。J Neurol Neurosurg Psychiatry，72，179-183。 | | 18. | Morrow, GR.、Gillies, LJ.、Hickok, JT.、Roscoe, JA.、Padmanaban, D.、Griggs, JJ.(2005)。The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed.。J Clin Oncol，23(suppl 16)，8012。 | | 19. | Jean-Pirrer, P.、Morrow, GR.、Roscoe, JA.(20100715)。A phase 3 randomized, placebocontrolled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy; a University of Rochester Cancer Center Community Clinical Oncology Program Research base study。Cancer，116(14)，3513-3520。 | | 20. | Holland, J. C.、Romano, S. J.、Heiligenstein, J. H.(1998)。A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer。Psycho-Oncology，7(4)，291-300。 | | 21. | Morrow, GR.、Hickok, JT.、Roscoe, JA.(2003)。Differential Effects of Paroxetine on Fatigue and Depression: A Randomized, Double-Blind Trial From the University of Rochester Cancer Center Community Clinical Oncology Program。J Clin Oncol，21(24)，4635-4641。 | | 22. | Roscoe, JA.、Morrow, GR.、Hickok, JT.(2005)。Effect of paroxetine hydrochloride (Paxil ®) on fatigue and depression in breast cancer patients receiving chemotherapy。Breast Cancer Res Treat，89(3)，243-249。 | | 23. | Cullum, JL.、Wojciechowski, AE.、Pelletier, G.、Simpson, JS.(2004)。Burpoprion sustained release treatment reduces fatigue in cancer patients。Can J Psychiatry，49，139-144。 | | 24. | Moss, E. L.、Simpson, J. S.、Pelletier, G.、Forsyth, P.(2006)。An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners。Psycho-Oncology，15，259-267。 | | 25. | Stockier, MR.、O'Conndl, R.、Nowak, AK.(2007)。Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial。The Lancet Oncology，8(7)，603-612。 | | 26. | Littlewood, TJ.、Kallich, JD.、Miguel, JS.、Hendricks, L.、Hedenus, M.(2006)。Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies。J Pain Symptom Manage，31(4)，317-325。 | | 27. | Carroll, JK.、Kohli, S.、Mustian, KM.、Roscoe, JA.、Morrow, GR.(2007)。Pharmacologic treatment of cancer-related fatigue。The Oncologist，12(suppl 1)，43-51。 | | 28. | Minton, O.、Richardson, A.、Sharp, M.、Hotopaf, M.、Stone, P.(2008)。A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer- Related Fatigue。JNCI，100(16)，1155-1166。 | | 29. | Bruera, E.、Roca, E.、Cedaro, L.、Carraro, S.、Chacon, R.(1985)。Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study。Cancer Treatment Report，69(7/8)，751-754。 | | 30. | Tannock, I.、Gorpodarowicz, M.、Meakin, W.(1989)。Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and'quality of life as pragmatic indices of response。J Clin Prev Control，7，590-597。 | | 31. | Hardy, JR.、Rees, E.、Ling, J.(200101)。A prospective survey of the use of dexamethasone on a palliative care unit。Palliate Med，15(1)，3-8。 | | 32. | Bruera, E.、Ernst, S.、Hagen, N.(1998)。Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study。Cancer Prevention and Control，2(2)，74-78。 | | 33. | Graziano, F.、Bisonni, R.、Catalano, V.(20020617)。Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients。BJC，86(12)，1854-1857。 | | 34. | Cruciani, RA.、Dvorkin, E.、Homel, P.(200612)。Safety, tolcrability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficicncy: a phase I/II study。J Pain Symptom Manage，32(6)，551-559。 | | 35. | Zhong, LLD.、Chen, HY.、Cho, WCS.、Meng, XM.、Tong, Y.(2012)。The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis。Complementary Therapies in Medicine，20(4)，240-252。 | | 36. | Qi, F.、Li, A.、Ingaki, Y.(2010)。Chinese herbal medicine as adjuvant treatment during chemo- or radio-therapy for cancer。BioScience Trends，4(6)，297-307。 | | 37. | Block, KI.、Mead, MN.(200309)。Immune system effects of Echinacea, ginseng, and astragalus: a review。Integr Cancer Ther，2(3)，247-267。 | | 38. | Barton, DL.、Soori, GS.、Bauer, BA.(2010)。Pilot study of Panax quinquefolius (American ginseng)to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA。Support Care Cancer，18(2)，179-187。 | | 39. | He, X.、Niu, X.、Li, J.、Xu, S.、Lu, A.(2012)。Immunomodulatory activities of five clinically used Chinese herbal polysaccharides。J Exp Integr Med，2(1)，15-27。 | | 40. | Yeimg, KS.、Gubili, J.、Cassileth, BR.(2011)。An evidence-based review of Astragalus membranaceus (Astragalus) for cancer patients。Evidence-based Anticancer Complementary and Alternative Mcdicine，65-84。 | | 41. | Lou, X.、Zhang, B.、Song, J.、Liu, B.、Deng, X.(2003)。Effect of Astragalus polysaccharide in stimulating the secretion of hematopoietic growth factors from activated human PAMC。Traditional Chinese Drug Research & Clinical Pharmacology，14，310-315。 | | 42. | Chen, HW.、Lin, IH.、Chen, YJ.(2012)。A novel influsible botanically-derived drug,PG2, for cancer-related fatigue: A phase II double-blind, randomized placebo-controlled study。Clin Invest Med，35(1)，E1-E11。 | | 43. | McCulloch, M.、See, C.、Shu, X.(2006)。Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Trials。J Clin Oncol，24，419-430。 | | 44. | Wu, T.、Munro, A.、Guanjian, L.、Liu, G. J.(2008)。Chinese medical herbs for chemotherapy side effects in colorectal cancer patients。The Cochrane Database of Systematic Reviews，1，CD004540。 | | 45. | Ulrich, D.(1998)。Intellectual capital = Competence × Commitment。Sloan Management Review，39(2)，15-26。 | 圖書| 1. | Hair, J. F.、Anderson, R. E.、Tatham, R. L.、Black, W. C.(1995)。Multivariate data analysis with readings。Upper Saddler River, NJ：Prentice-Hall。 | | 2. | Cohen, J.(1988)。Statistical power and analysis for the behavioral sciences。Hillsdale, NJ：Lawrence Erlbaum Associates。 | 其他| 1. | NCCN clinical practice guidelines in oncology: Cancer-related Fatigue Version 1 2012，http://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf.， 20120616。 | | 2. | NCCN clinical practice guidelines in oncology: cancer and chemotherapy-induced anemia Version 1 2013，http://www.nccn.org/professionals/physician_gls/pdf/ anemia.pdf.， 20120618。 | | 3. | 台灣食品藥物管理局(20100621)。特定食品適量吃，有病就醫真安康，http://www.fda.gov.tw/news.aspx7newssn=4915&ciassifysn=4。 延伸查詢 | | 4. | (20130121)。人參(Ginseng)可能之副作用及交互作用，http://hf.doh.gov.tw/TDRF_HUAS/Huas/NoticeContent.aspx?NOTICE_CODE-320。 | |
| |